GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzon Pharmaceuticals Inc (STU:EZ1) » Definitions » Institutional Ownership

Enzon Pharmaceuticals (STU:EZ1) Institutional Ownership : 0.02% (As of Apr. 15, 2025)


View and export this data going back to . Start your Free Trial

What is Enzon Pharmaceuticals Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Enzon Pharmaceuticals's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Enzon Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Enzon Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 40.58%.


Enzon Pharmaceuticals Institutional Ownership Historical Data

The historical data trend for Enzon Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzon Pharmaceuticals Institutional Ownership Chart

Enzon Pharmaceuticals Historical Data

The historical data trend for Enzon Pharmaceuticals can be seen below:

2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02

Enzon Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Enzon Pharmaceuticals Business Description

Traded in Other Exchanges
Address
20 Commerce Drive, Suite 135, Cranford, NJ, USA, 07016
Enzon Pharmaceuticals Inc is positioned as a public company acquisition vehicle, where the Company can become an acquisition platform and more fully utilize its net operating loss carryforwards and enhance stockholder value.

Enzon Pharmaceuticals Headlines

No Headlines